Innate Pharma S.A. Sponsored ADR (IPHA)
Market Closed
17 Jul, 20:00
$
1. 75
-0.02
-1.4085%
$
168.09M Market Cap
- P/E Ratio
- Div Yield
10,400 Volume
0 Eps
$ 1.77
Previous Close Investors:
Want to track IPHA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Innate Pharma S.A. Sponsored ADR (IPHA) Statistics
Valuation metrics
Market Cap 168.09M
Enterprise value 136.09M
Trailing P/E (ttm) -2.74
Forward P/E -
PEG ratio -0.28
Price/Sales (ttm) 50.81
Price/Book (mrq) -6.35
Enterprise Value/Revenue 48.83
Enterprise Value/EBITDA -2.43
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 10.43K
Average volume (90 days) 121.21K
Price summary
52-Week low 1.17
52-Week high 2.63
Beta -
50-Day moving average 1.78
200-Day moving average 1.62
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -17.65%
Operating margin -20.58%
Operational effectiveness
Return on assets -0.78%
Return on equity 5.94%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.03
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.54
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.38
Total debt (mrq) -
Total Debt/Equity (mrq) -1.04
Current ratio (mrq) 1.27%
Book value per share (mrq) -0.24
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
